Radiotherapy Commission


Radiotherapy Commission is a specific FIL Commission.

Radiotherapy is an important therapeutic option in the treatment of lymphomas. In relation to different types of lymphoma and to the different presentations of the disease, it can be used as the sole treatment or in combination with systemic treatments (chemotherapy, chemoimmunotherapy). Over the years, there has been a gradual reduction in the volume irradiated and the doses administered, useful to significantly reduce the risk of late toxicities of older treatment. In fact, thanks to the important technological progress which covered all stages of radiotherapy treatment, modern radiotherapy is now increasingly able to administer the required dose in a very accurate way, with more and better savings of surrounding healthy tissue, and with further improvement of the therapeutic index. 


The objectives of this Radiotherapy Commission are: 

  1. Disseminate guidelines relating to modern radiotherapy in Lymphomas; 
  2. Promoting initiatives retrospective and prospective of Quality Assurance (QA) in Radiotherapy;
  3. Cooperate with other FIL Commissions to contribute to the improvement in treatments of lymphoma; 
  4. Promote analysis regarding radiotherapy used in clinical trials;
  5. Create regional networks for the dissemination of modern radiotherapy inItaly, promoting educational initiatives within the haematological and radiotherapy communities. 


Prof. Andrea Filippi -  Responsabile Commissione FIL Radioterapia

The Radiotherapy Commission is coordinated by Dr. Andrea Riccardo Filippi,  Radiotherapist at IRCCS Policlinico San Matteo in Pavia.